SciELO - Scientific Electronic Library Online

 
vol.80 issue3Case for diagnosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Anais Brasileiros de Dermatologia

On-line version ISSN 1806-4841

An. Bras. Dermatol. vol.80 no.3 Rio de Janeiro May/June 2005

http://dx.doi.org/10.1590/S0365-05962005000300016 

ICONOGRAPHY

 

Comparative Dermatology*

 

 

Hiram Larangeira de Almeida Jr

Associate Professor of Dermatology at Universidade Federal de Pelotas and Master's Degree Program in Health and Behavior at Universidade Católica de Pelotas (RS)

Correspondence

 

 


ABSTRACT

The impressive facial angiofibromas, from a 32 year-old male paciente, with the classical features of tuberous sclerosis, were compared with mulberries.

Keywords: Angiofibroma; Facial dermatoses; Tuberous sclerosis


 

 

ANGIOFIBROMAS MORIFORMES

Tuberous sclerosis, a disease that belongs to the group of neurocutaneous disorders, is also called Bourneville Disease, after the physician who first related the cutaneous lesions to the neurologic affection. The term epiloia is also used, albeit with less acceptance in the Anglo-Saxonic literature.1

The classical cutaneous picture consists of multiple face angiofibromas, mistakenly called sebaceous adenomas, which are preferentially located in the nasogenal sulci, malar regions and mentum. Leaf-shaped hipomellanotic macullae, periungueal fibromas and fibrotic plaquae in the lumbossacral region complete the dermatological picture.1

The genetic defect was described in genes TSC1 and TSC2, and it is possible to detect the causing mutation in 90% of the cases.2 Affection of gene TSC2 leads to more severe clinical pictures. Gene TSC1 is located in chromosome 9 and encodes hamartine; gene TSC2 encodes tuberine and is located in chromosome 16.3

These two proteins interact in a not fully understood manner, being tumoral supressors;4 the absence or dysfunction of one or the other leads to the picture of tuberous sclerosis. It has already been shown that an enhanced expression of these proteins inhibits cellular proliferation and that mutant animals that do not express them exhibit reduction of mitosis time.4 Likewise, a smaller expression of these two proteins has been demonstrated in fibroepithelial polypi. Thus, they are likely to be involved in other illnesses involving tissue hypertrophy/hyperplasia.5

A 32 year-old white male with a characteristic picture of tuberous sclerosis was examined. His angiofibromas began during childhood, having a typical location on the nasogenal sulcus (Figure 1) and mentum (Figure 2). However, the lesions were very exuberant, acquiring an unequivocal mulberry-like aspect (Figure 3). This patient also presented convulsions with a normal neuropsychomotor development, reflecting the known lack of parallelism between the neurologic and cutaneous pictures,1 such as seen in this patient. q

 

 

 

 

 

 

REFERENCES

1. Short MP, Adams RD. Neurocutaneous diseases. In: Fitzpatrick T, Eisen AZ, Wolff K, Freedberg IM, Austen KR, editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill;1993. p. 2249-90.        [ Links ]

2. MacCollin M, Kwiatkowski D. Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1. Curr Opin Neurol. 2001; 14: 163-9.        [ Links ]

3. Narayanan V. Tuberous sclerosis complex: genetics to pathogenesis. Pediatr Neurol. 2003; 29:404-9.        [ Links ]

4. Hodges AK, Li S, Maynard J, Parry L, Braverman R, Cheadle JP, et al. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. Hum Mol Genet. 2001; 10: 2899-905.        [ Links ]

5. Wu J, Khalil FK, Keehn CA, Saeed S, Morgan MB. Hamartin and tuberin immunohistochemical expression in cutaneous fibroepithelial polyps. J Cutan Pathol. 2004; 31: 383-7.        [ Links ]

 

 

Correspondence to
Prof. Dr. Hiram Larangeira de Almeida Jr.
Departamento de Medicina Especializada
Faculdade de Medicina da UFPEL
Av. Duque de Caxias, 250
96030-002 - Pelotas - RS
E-mail: hiramalmeidajr@hotmail.com

Received on May 17, 2004.
Approved by the Editorial Council and accepted for publication on August 07, 2004.

 

 

* Work done at Faculdade de Medicina da Universidade Federal de Pelotas (RS) - Brazil.